BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amirian A, Mahani MB, Abdi F. Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus. Obstet Gynecol Sci 2020;63:407-16. [PMID: 32689769 DOI: 10.5468/ogs.20020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Rahnemaei FA, Abdi F, Kazemian E, Shaterian N, Shaterian N, Behesht Aeen F. Association between body mass index in the first half of pregnancy and gestational diabetes: A systematic review. SAGE Open Med 2022;10:20503121221109911. [PMID: 35898952 DOI: 10.1177/20503121221109911] [Reference Citation Analysis]
2 Du R, Li L, Wang Y. N6-Methyladenosine-Related Gene Signature Associated With Monocyte Infiltration Is Clinically Significant in Gestational Diabetes Mellitus. Front Endocrinol 2022;13:853857. [DOI: 10.3389/fendo.2022.853857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Vasilakos LK, Steinbrekera B, Santillan DA, Santillan MK, Brandt DS, Dagle D, Roghair RD. Umbilical Cord Blood Leptin and IL-6 in the Presence of Maternal Diabetes or Chorioamnionitis. Front Endocrinol 2022;13:836541. [DOI: 10.3389/fendo.2022.836541] [Reference Citation Analysis]
4 Rahnemaei FA, Pakzad R, Amirian A, Pakzad I, Abdi F. Effect of gestational diabetes mellitus on lipid profile: A systematic review and meta-analysis. Open Med (Wars) 2022;17:70-86. [PMID: 34993347 DOI: 10.1515/med-2021-0408] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Naeh A, Maor-sagie E, Hallak M, Gabbay-benziv R. Early Identification of the Maternal, Placental and Fetal Dialog in Gestational Diabetes and Its Prevention. Reprod Med 2022;3:1-14. [DOI: 10.3390/reprodmed3010001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Fan W, Kang W, Li T, Luo D, Huang L, Yang Y, Sun Y. Interleukin-33 and its receptor soluble suppression of tumorigenicity 2 in the diagnosis of gestational diabetes mellitus. Int J Clin Pract 2021;75:e14944. [PMID: 34605145 DOI: 10.1111/ijcp.14944] [Reference Citation Analysis]
7 Sagrillo-Fagundes L, Casagrande Paim T, Pretto L, Bertaco I, Zanatelli C, Vaillancourt C, Wink MR. The implications of the purinergic signaling throughout pregnancy. J Cell Physiol 2021. [PMID: 34596240 DOI: 10.1002/jcp.30594] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Huang X, Zha B, Zhang M, Li Y, Wu Y, Zhang R, Sheng L, Xu J, Yu Z, Gao C, Chen Z, Ding H, Ma L, Zhang Y, Zang S, Zhang TN, Liu J. Decreased Monocyte Count is Associated with Gestational Diabetes Mellitus Development, Macrosomia and Inflammation. J Clin Endocrinol Metab 2021:dgab657. [PMID: 34478541 DOI: 10.1210/clinem/dgab657] [Reference Citation Analysis]
9 Du R, Wu N, Li L. Aberrantly Expressed Non-Coding RNAs in the Placenta and Their Role in the Pathophysiology of Gestational Diabetes Mellitus. Diabetes Metab Syndr Obes 2021;14:3719-32. [PMID: 34456579 DOI: 10.2147/DMSO.S325993] [Reference Citation Analysis]
10 Bogdanet D, Reddin C, Murphy D, Doheny HC, Halperin JA, Dunne F, O'Shea PM. Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes-A Scoping Review. J Clin Med 2021;10:1533. [PMID: 33917484 DOI: 10.3390/jcm10071533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]